Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT

Cogent Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 4.29M n/a n/a n/a 5.59M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.16M 1.14M n/a 1.1M 1.08M 1.07M 794K 855K 1.22M 723K 937K 3.71M 97K 69K 68K 48K 14K 17K
Gross Profit
-1.16M -1.14M 2.15M -1.1M -1.08M -1.07M 4.79M -855K -1.22M -723K -937K -3.71M -97K -69K -68K -48K -14K -17K
Operating Income
-75.58M -74.93M -73.73M -75.41M -64.39M -62.4M -58.23M -59.58M -47.09M -43.24M -43.74M -36.82M -35.85M -31.42M -25.64M -19.82M -17.29M -12.8M
Interest Income
2.37M 2.95M 3.86M 4.78M 5.39M 4.06M 3.87M 4.2M 2.74M 2.27M 2.11M 1.5M 272K 107K 107K 115K 120K 125K
Pretax Income
-73.53M -71.99M -67.93M -70.63M -58.95M -58.35M -54.37M -55.38M -44.08M -38.59M -39.62M -35.06M -34.93M -30.63M -24.91M -19.08M -16.55M -11.73M
Net Income
-73.53M -71.99M -67.93M -70.63M -58.95M -58.35M -54.37M -55.38M -44.08M -33.94M -35.49M -33.3M -34.93M -29.85M -24.91M -19.08M -16.55M -11.73M
Selling & General & Admin
13.38M 11.9M 11.69M 11.8M 10.09M 9.7M 9.51M 9.45M 8.21M 7.2M 7M 6.88M 6.38M 5.95M 5.13M 5.02M 4.9M 4.59M
Research & Development
61.05M 63.03M 62.05M 63.61M 54.29M 52.7M 48.72M 50.13M 38.87M 36.04M 36.74M 29.94M 29.48M 25.47M 20.51M 14.8M 12.39M 8.21M
Other Expenses
n/a n/a n/a n/a n/a -1K -7K n/a 268K 2.38M 2.02M 259K n/a n/a n/a n/a n/a n/a
Operating Expenses
74.42M 74.93M 73.73M 75.41M 64.39M 62.4M 58.23M 59.58M 47.09M 43.24M 43.74M 36.82M 35.85M 31.42M 25.64M 19.82M 17.29M 12.8M
Interest Expense
314K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
75.58M 74.93M 73.73M 75.41M 64.39M 62.4M 58.23M 59.58M 47.09M 43.24M 43.74M 36.82M 35.85M 31.42M 25.64M 19.82M 17.29M 12.8M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.65M -4.13M -1.76M n/a -784K n/a -115K -120K n/a
Shares Outstanding (Basic)
114.47M 113.31M 110.46M 110.17M 99.24M 94.8M 86.73M 86.17M 74.75M 70.73M 70.49M 69.58M 49.39M 45.11M 43.81M 39.85M 38.44M 34.88M
Shares Outstanding (Diluted)
114.47M 113.31M 110.46M 110.17M 99.24M 94.8M 86.73M 86.17M 74.75M 70.73M 70.49M 69.58M 49.39M 45.11M 43.81M 39.85M 38.44M 34.88M
EPS (Basic)
-0.64 -0.52 -0.61 -0.64 -0.59 -0.62 -0.63 -0.64 -0.59 -0.48 -0.5 -0.48 -0.71 -0.66 -0.57 -0.48 -0.43 -0.34
EPS (Diluted)
-0.64 -0.52 -0.61 -0.64 -0.59 -0.62 -0.63 -0.64 -0.59 -0.48 -0.5 -0.48 -0.71 -0.66 -0.57 -0.48 -0.43 -0.34
EBITDA
-72.06M -73.8M -66.77M -74.32M -63.31M -61.8M -57.63M -59M -46.52M -42.71M -43.33M -31.35M -35.76M -31.35M -25.57M -19.77M -17.28M -12.78M
EBIT
-73.22M -74.93M -67.93M -75.41M -64.39M -62.4M -58.23M -59.58M -47.09M -43.24M -43.74M -36.82M -35.85M -31.42M -25.64M -19.82M -17.29M -12.8M
Depreciation & Amortization
1.16M 1.14M 1.16M 1.1M 1.08M 1.07M 794K 855K 1.22M 723K 937K 3.71M 97K 69K 68K 48K 14K 17K